APO Research
Talk to an analyst

APO RESEARCH · REPORT

Voriconazole

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Voriconazole Industry Growth and Trends Forecast to 2032

26 December 2025117 pages

Choose your research edition.

Industry ResearchVoriconazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Voriconazole Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Voriconazole Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Voriconazole Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Voriconazole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Voriconazole include Abbott, Takeda, Teva, Sandoz, 诺华, Mylan, Pfizer, GSK and Taj Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Voriconazole market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Voriconazole market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Voriconazole market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Voriconazole.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Voriconazole market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Voriconazole Market by Company

Abbott

Takeda

Teva

Sandoz

诺华

Mylan

Pfizer

GSK

Taj Pharmaceuticals

Squibb

Sichuan Beauty Sport Huakang Pharmaceutical

Macherey-Nagel GmbH

Jincheng HEALTH Pharmaceutical

GeneTech Pharm

Ebang Pharmaceutical

Daiichi Sankyo

Cilag AG

Aditya Pharma

Voriconazole Segment by Type

Injection Voriconazole

Voriconazole Freeze-dried Powder

Voriconazole Segment by Application

Hospital

Clinic

Other

Voriconazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voriconazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voriconazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voriconazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Voriconazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Voriconazole Table 2. Major Company of Voriconazole Freeze-dried Powder Table 3. Global Voriconazole Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Voriconazole Sales by Type (2021-2026) & (K Units) Table 5. Global Voriconazole Sales Market Share in Volume by Type (2021-2026) Table 6. Global Voriconazole Sales by Type (2021-2026) & (US$ Million) Table 7. Global Voriconazole Sales Market Share in Value by Type (2021-2026) Table 8. Global Voriconazole Price by Type (2021-2026) & (US$/Unit) Table 9. Global Voriconazole Sales by Type (2027-2032) & (K Units) Table 10. Global Voriconazole Sales Market Share in Volume by Type (2027-2032) Table 11. Global Voriconazole Sales by Type (2027-2032) & (US$ Million) Table 12. Global Voriconazole Sales Market Share in Value by Type (2027-2032) Table 13. Global Voriconazole Price by Type (2027-2032) & (US$/Unit) Table 14. North America Voriconazole Sales by Type (2021-2026) & (K Units) Table 15. North America Voriconazole Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Voriconazole Sales by Type (2021-2026) & (K Units) Table 17. Europe Voriconazole Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Voriconazole Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Voriconazole Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Voriconazole Sales by Type (2021-2026) & (K Units) Table 21. Latin America Voriconazole Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Voriconazole Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Voriconazole Sales by Type (2021-2026) & (US$ Million) Table 24. Voriconazole Industry Trends Table 25. Voriconazole Industry Drivers Table 26. Voriconazole Industry Opportunities and Challenges Table 27. Voriconazole Industry Restraints Table 28. Global Voriconazole Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Voriconazole Revenue Market Share by Company (2021-2026) Table 30. Global Voriconazole Sales by Company (2021-2026) & (K Units) Table 31. Global Voriconazole Sales Share by Company (2021-2026) Table 32. Global Voriconazole Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Voriconazole Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Voriconazole Major Company Production Sites and Headquarters Table 35. Global Voriconazole Company, Product Type & Application Table 36. Global Voriconazole Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Voriconazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Voriconazole Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Voriconazole Sales by Region (2021-2026) & (K Units) Table 41. Global Voriconazole Sales Market Share in Volume by Region (2021-2026) Table 42. Global Voriconazole Sales by Region (2021-2026) & (US$ Million) Table 43. Global Voriconazole Sales Market Share in Value by Region (2021-2026) Table 44. Global Voriconazole Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Voriconazole Sales by Region (2027-2032) & (K Units) Table 46. Global Voriconazole Sales Market Share in Volume by Region (2027-2032) Table 47. Global Voriconazole Sales by Region (2027-2032) & (US$ Million) Table 48. Global Voriconazole Sales Market Share in Value by Region (2027-2032) Table 49. Global Voriconazole Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Voriconazole Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Voriconazole Sales by Application (2021-2026) & (K Units) Table 52. Global Voriconazole Sales Market Share in Volume by Application (2021-2026) Table 53. Global Voriconazole Sales by Application (2021-2026) & (US$ Million) Table 54. Global Voriconazole Sales Market Share in Value by Application (2021-2026) Table 55. Global Voriconazole Price by Application (2021-2026) & (US$/Unit) Table 56. Global Voriconazole Sales by Application (2027-2032) & (K Units) Table 57. Global Voriconazole Sales Market Share in Volume by Application (2027-2032) Table 58. Global Voriconazole Sales by Application (2027-2032) & (US$ Million) Table 59. Global Voriconazole Sales Market Share in Value by Application (2027-2032) Table 60. Global Voriconazole Price by Application (2027-2032) & (US$/Unit) Table 61. North America Voriconazole Sales by Application (2021-2026) & (K Units) Table 62. North America Voriconazole Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Voriconazole Sales by Application (2021-2026) & (K Units) Table 64. Europe Voriconazole Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Voriconazole Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Voriconazole Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Voriconazole Sales by Application (2021-2026) & (K Units) Table 68. Latin America Voriconazole Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Voriconazole Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Voriconazole Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Abbott Voriconazole Product Portfolio Table 75. Abbott Recent Development Table 76. Takeda Company Information Table 77. Takeda Business Overview Table 78. Takeda Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Takeda Voriconazole Product Portfolio Table 80. Takeda Recent Development Table 81. Teva Company Information Table 82. Teva Business Overview Table 83. Teva Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Teva Voriconazole Product Portfolio Table 85. Teva Recent Development Table 86. Sandoz Company Information Table 87. Sandoz Business Overview Table 88. Sandoz Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sandoz Voriconazole Product Portfolio Table 90. Sandoz Recent Development Table 91. 诺华 Company Information Table 92. 诺华 Business Overview Table 93. 诺华 Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. 诺华 Voriconazole Product Portfolio Table 95. 诺华 Recent Development Table 96. Mylan Company Information Table 97. Mylan Business Overview Table 98. Mylan Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Mylan Voriconazole Product Portfolio Table 100. Mylan Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Voriconazole Product Portfolio Table 105. Pfizer Recent Development Table 106. GSK Company Information Table 107. GSK Business Overview Table 108. GSK Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. GSK Voriconazole Product Portfolio Table 110. GSK Recent Development Table 111. Taj Pharmaceuticals Company Information Table 112. Taj Pharmaceuticals Business Overview Table 113. Taj Pharmaceuticals Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Taj Pharmaceuticals Voriconazole Product Portfolio Table 115. Taj Pharmaceuticals Recent Development Table 116. Squibb Company Information Table 117. Squibb Business Overview Table 118. Squibb Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Squibb Voriconazole Product Portfolio Table 120. Squibb Recent Development Table 121. Sichuan Beauty Sport Huakang Pharmaceutical Company Information Table 122. Sichuan Beauty Sport Huakang Pharmaceutical Business Overview Table 123. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio Table 125. Sichuan Beauty Sport Huakang Pharmaceutical Recent Development Table 126. Macherey-Nagel GmbH Company Information Table 127. Macherey-Nagel GmbH Business Overview Table 128. Macherey-Nagel GmbH Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Macherey-Nagel GmbH Voriconazole Product Portfolio Table 130. Macherey-Nagel GmbH Recent Development Table 131. Jincheng HEALTH Pharmaceutical Company Information Table 132. Jincheng HEALTH Pharmaceutical Business Overview Table 133. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio Table 135. Jincheng HEALTH Pharmaceutical Recent Development Table 136. GeneTech Pharm Company Information Table 137. GeneTech Pharm Business Overview Table 138. GeneTech Pharm Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. GeneTech Pharm Voriconazole Product Portfolio Table 140. GeneTech Pharm Recent Development Table 141. Ebang Pharmaceutical Company Information Table 142. Ebang Pharmaceutical Business Overview Table 143. Ebang Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Ebang Pharmaceutical Voriconazole Product Portfolio Table 145. Ebang Pharmaceutical Recent Development Table 146. Daiichi Sankyo Company Information Table 147. Daiichi Sankyo Business Overview Table 148. Daiichi Sankyo Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Daiichi Sankyo Voriconazole Product Portfolio Table 150. Daiichi Sankyo Recent Development Table 151. Cilag AG Company Information Table 152. Cilag AG Business Overview Table 153. Cilag AG Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Cilag AG Voriconazole Product Portfolio Table 155. Cilag AG Recent Development Table 156. Aditya Pharma Company Information Table 157. Aditya Pharma Business Overview Table 158. Aditya Pharma Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Aditya Pharma Voriconazole Product Portfolio Table 160. Aditya Pharma Recent Development Table 161. North America Voriconazole Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. North America Voriconazole Sales by Country (2021-2026) & (K Units) Table 163. North America Voriconazole Sales Market Share by Country (2021-2026) Table 164. North America Voriconazole Sales Forecast by Country (2027-2032) & (K Units) Table 165. North America Voriconazole Sales Market Share Forecast by Country (2027-2032) Table 166. North America Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 168. North America Voriconazole Market Share by Country (2021-2026) Table 169. North America Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America Voriconazole Market Share Forecast by Country (2027-2032) Table 171. Europe Voriconazole Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Europe Voriconazole Sales by Country (2021-2026) & (K Units) Table 173. Europe Voriconazole Sales Market Share by Country (2021-2026) Table 174. Europe Voriconazole Sales Forecast by Country (2027-2032) & (K Units) Table 175. Europe Voriconazole Sales Market Share Forecast by Country (2027-2032) Table 176. Europe Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe Voriconazole Market Share by Country (2021-2026) Table 179. Europe Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe Voriconazole Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Voriconazole Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Voriconazole Sales by Country (2021-2026) & (K Units) Table 183. Asia-Pacific Voriconazole Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific Voriconazole Sales Forecast by Country (2027-2032) & (K Units) Table 185. Asia-Pacific Voriconazole Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific Voriconazole Market Share by Country (2021-2026) Table 189. Asia-Pacific Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific Voriconazole Market Share Forecast by Country (2027-2032) Table 191. Latin America Voriconazole Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Latin America Voriconazole Sales by Country (2021-2026) & (K Units) Table 193. Latin America Voriconazole Sales Market Share by Country (2021-2026) Table 194. Latin America Voriconazole Sales Forecast by Country (2027-2032) & (K Units) Table 195. Latin America Voriconazole Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America Voriconazole Market Share by Country (2021-2026) Table 199. Latin America Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America Voriconazole Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Voriconazole Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Voriconazole Sales by Country (2021-2026) & (K Units) Table 203. Middle East and Africa Voriconazole Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa Voriconazole Sales Forecast by Country (2027-2032) & (K Units) Table 205. Middle East and Africa Voriconazole Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa Voriconazole Market Share by Country (2021-2026) Table 209. Middle East and Africa Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa Voriconazole Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Voriconazole Distributors List Table 214. Voriconazole Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Voriconazole Image Figure 2. Global Voriconazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Voriconazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Voriconazole Sales (2021-2032) & (K Units) Figure 5. Injection Voriconazole Image Figure 6. Global Injection Voriconazole Sales YoY Growth (2021-2032) & (K Units) Figure 7. Voriconazole Freeze-dried Powder Image Figure 8. Global Voriconazole Freeze-dried Powder Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Voriconazole Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Voriconazole Market Share by Type 2025 VS 2032 Figure 11. North America Voriconazole Sales Market Share in Volume by Type in 2025 Figure 12. North America Voriconazole Sales Market Share in Value by Type in 2025 Figure 13. Europe Voriconazole Sales Market Share in Volume by Type in 2025 Figure 14. Europe Voriconazole Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Voriconazole Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Voriconazole Sales Market Share in Value by Type in 2025 Figure 17. Latin America Voriconazole Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Voriconazole Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Voriconazole Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Voriconazole Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Voriconazole Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Voriconazole Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Voriconazole Market Share by Application 2025 VS 2032 Figure 31. North America Voriconazole Sales Market Share in Volume by Application in 2025 Figure 32. North America Voriconazole Sales Market Share in Value by Application in 2025 Figure 33. Europe Voriconazole Sales Market Share in Volume by Application in 2025 Figure 34. Europe Voriconazole Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Voriconazole Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Voriconazole Sales Market Share in Value by Application in 2025 Figure 37. Latin America Voriconazole Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Voriconazole Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Voriconazole Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Voriconazole Sales Market Share in Value by Application in 2025 Figure 41. North America Voriconazole Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Voriconazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Voriconazole Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Voriconazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Voriconazole Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Voriconazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Voriconazole Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Voriconazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Voriconazole Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Voriconazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Voriconazole Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Voriconazole Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Voriconazole
  • Voriconazole Freeze-dried Powder
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Takeda
  • Teva
  • Sandoz
  • 诺华
  • Mylan
  • Pfizer
  • GSK
  • Taj Pharmaceuticals
  • Squibb
  • Sichuan Beauty Sport Huakang Pharmaceutical
  • Macherey-Nagel GmbH
  • Jincheng HEALTH Pharmaceutical
  • GeneTech Pharm
  • Ebang Pharmaceutical
  • Daiichi Sankyo
  • Cilag AG
  • Aditya Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Voriconazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Voriconazole Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Voriconazole Market by Type
  6. 1.3.1 Injection Voriconazole
  7. 1.3.2 Voriconazole Freeze-dried Powder
  8. 1.4 Global Voriconazole Market Size by Type
  9. 1.4.1 Global Voriconazole Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Voriconazole Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Voriconazole Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Voriconazole Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Voriconazole Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Voriconazole Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Voriconazole Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Voriconazole Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Voriconazole Industry Trends
  2. 2.2 Voriconazole Industry Drivers
  3. 2.3 Voriconazole Industry Opportunities and Challenges
  4. 2.4 Voriconazole Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Voriconazole Revenue (2021-2026)
  2. 3.2 Global Top Players by Voriconazole Sales (2021-2026)
  3. 3.3 Global Top Players by Voriconazole Price (2021-2026)
  4. 3.4 Global Voriconazole Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Voriconazole Major Company Production Sites & Headquarters
  6. 3.6 Global Voriconazole Company, Product Type & Application
  7. 3.7 Global Voriconazole Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Voriconazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Voriconazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Voriconazole Tier 1, Tier 2, and Tier 3
4 Voriconazole Regional Status and Outlook
  1. 4.1 Global Voriconazole Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Voriconazole Historic Market Size by Region
  3. 4.2.1 Global Voriconazole Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Voriconazole Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Voriconazole Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Voriconazole Forecasted Market Size by Region
  7. 4.3.1 Global Voriconazole Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Voriconazole Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Voriconazole Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Voriconazole by Application
  1. 5.1 Voriconazole Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Voriconazole Market Size by Application
  6. 5.2.1 Global Voriconazole Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Voriconazole Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Voriconazole Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Voriconazole Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Voriconazole Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Voriconazole Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Voriconazole Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Voriconazole Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Voriconazole Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Voriconazole Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Voriconazole Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Sandoz
  20. 6.4.1 Sandoz Company Information
  21. 6.4.2 Sandoz Business Overview
  22. 6.4.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz Voriconazole Product Portfolio
  24. 6.4.5 Sandoz Recent Developments
  25. 6.5 诺华
  26. 6.5.1 诺华 Company Information
  27. 6.5.2 诺华 Business Overview
  28. 6.5.3 诺华 Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 诺华 Voriconazole Product Portfolio
  30. 6.5.5 诺华 Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Voriconazole Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Voriconazole Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK Voriconazole Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Taj Pharmaceuticals
  50. 6.9.1 Taj Pharmaceuticals Company Information
  51. 6.9.2 Taj Pharmaceuticals Business Overview
  52. 6.9.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Taj Pharmaceuticals Voriconazole Product Portfolio
  54. 6.9.5 Taj Pharmaceuticals Recent Developments
  55. 6.10 Squibb
  56. 6.10.1 Squibb Company Information
  57. 6.10.2 Squibb Business Overview
  58. 6.10.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Squibb Voriconazole Product Portfolio
  60. 6.10.5 Squibb Recent Developments
  61. 6.11 Sichuan Beauty Sport Huakang Pharmaceutical
  62. 6.11.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
  63. 6.11.2 Sichuan Beauty Sport Huakang Pharmaceutical Business Overview
  64. 6.11.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio
  66. 6.11.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments
  67. 6.12 Macherey-Nagel GmbH
  68. 6.12.1 Macherey-Nagel GmbH Company Information
  69. 6.12.2 Macherey-Nagel GmbH Business Overview
  70. 6.12.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Macherey-Nagel GmbH Voriconazole Product Portfolio
  72. 6.12.5 Macherey-Nagel GmbH Recent Developments
  73. 6.13 Jincheng HEALTH Pharmaceutical
  74. 6.13.1 Jincheng HEALTH Pharmaceutical Company Information
  75. 6.13.2 Jincheng HEALTH Pharmaceutical Business Overview
  76. 6.13.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio
  78. 6.13.5 Jincheng HEALTH Pharmaceutical Recent Developments
  79. 6.14 GeneTech Pharm
  80. 6.14.1 GeneTech Pharm Company Information
  81. 6.14.2 GeneTech Pharm Business Overview
  82. 6.14.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 GeneTech Pharm Voriconazole Product Portfolio
  84. 6.14.5 GeneTech Pharm Recent Developments
  85. 6.15 Ebang Pharmaceutical
  86. 6.15.1 Ebang Pharmaceutical Company Information
  87. 6.15.2 Ebang Pharmaceutical Business Overview
  88. 6.15.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ebang Pharmaceutical Voriconazole Product Portfolio
  90. 6.15.5 Ebang Pharmaceutical Recent Developments
  91. 6.16 Daiichi Sankyo
  92. 6.16.1 Daiichi Sankyo Company Information
  93. 6.16.2 Daiichi Sankyo Business Overview
  94. 6.16.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Daiichi Sankyo Voriconazole Product Portfolio
  96. 6.16.5 Daiichi Sankyo Recent Developments
  97. 6.17 Cilag AG
  98. 6.17.1 Cilag AG Company Information
  99. 6.17.2 Cilag AG Business Overview
  100. 6.17.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Cilag AG Voriconazole Product Portfolio
  102. 6.17.5 Cilag AG Recent Developments
  103. 6.18 Aditya Pharma
  104. 6.18.1 Aditya Pharma Company Information
  105. 6.18.2 Aditya Pharma Business Overview
  106. 6.18.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Aditya Pharma Voriconazole Product Portfolio
  108. 6.18.5 Aditya Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Voriconazole Sales by Country
  2. 7.1.1 North America Voriconazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Voriconazole Sales by Country (2021-2026)
  4. 7.1.3 North America Voriconazole Sales Forecast by Country (2027-2032)
  5. 7.2 North America Voriconazole Market Size by Country
  6. 7.2.1 North America Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Voriconazole Market Size by Country (2021-2026)
  8. 7.2.3 North America Voriconazole Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Voriconazole Sales by Country
  2. 8.1.1 Europe Voriconazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Voriconazole Sales by Country (2021-2026)
  4. 8.1.3 Europe Voriconazole Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Voriconazole Market Size by Country
  6. 8.2.1 Europe Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Voriconazole Market Size by Country (2021-2026)
  8. 8.2.3 Europe Voriconazole Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Voriconazole Sales by Country
  2. 9.1.1 Asia-Pacific Voriconazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Voriconazole Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Voriconazole Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Voriconazole Market Size by Country
  6. 9.2.1 Asia-Pacific Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Voriconazole Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Voriconazole Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Voriconazole Sales by Country
  2. 10.1.1 South America Voriconazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Voriconazole Sales by Country (2021-2026)
  4. 10.1.3 South America Voriconazole Sales Forecast by Country (2027-2032)
  5. 10.2 South America Voriconazole Market Size by Country
  6. 10.2.1 South America Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Voriconazole Market Size by Country (2021-2026)
  8. 10.2.3 South America Voriconazole Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Voriconazole Sales by Country
  2. 11.1.1 Middle East and Africa Voriconazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Voriconazole Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Voriconazole Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Voriconazole Market Size by Country
  6. 11.2.1 Middle East and Africa Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Voriconazole Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Voriconazole Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Voriconazole Value Chain Analysis
  2. 12.1.1 Voriconazole Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Voriconazole Production Mode & Process
  7. 12.2 Voriconazole Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Voriconazole Distributors
  10. 12.2.3 Voriconazole Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst